This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Extrahepatic bile ducts
CD2_BENIGN_EXTRAHEPATIC_BILE_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum ductuum biliarium extrahepaticorum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Extrahepatic bile ducts
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Extrahepatic bile ducts
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm: Liver/bile ducts
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasm of other and ill-defined parts of digestive system
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 98 | 54 | 44 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 59.65 | 54.98 | 65.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 90
- Matched controls
- 898
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.5
ICD-10 Finland
Benign neoplasm: Extrahepatic bile ducts
+∞
116.9
85
*
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
12.4
21.0
42
59
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
163.5
13.9
14
*
UJK02
NOMESCO Finland
ERCP
40.8
11.6
14
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
111.1
9.6
10
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
41.2
9.2
11
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
98.8
8.6
9
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
27.7
7.7
10
*
130
Kela drug reimbursment
Malignant tumour
+∞
7.4
7
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
43.4
6.9
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.1
6.5
14
20
A04AA02
ATC
granisetron; systemic, transdermal
74.9
6.5
7
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
4.5
6.2
22
60
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.1
6.0
42
196
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
38
11.47
25.00
2.3
1.1
ug/l
2.8
3.0
0.08
25
28
(3002256) Pathology report gross observation
24
59
5.06
9.64
1.3
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
57
314
2.95
6.42
4.0
3.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
46
256
2.50
4.68
2.7
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
54
337
2.34
4.12
10.8
5.1
mmol/l
1.2
1.2
0.39
47
283
(4035726)
10
25
4.34
3.80
1.8
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
61
415
2.24
3.62
8.6
5.7
e9/l
4.9
4.3
1.00
55
351
(40768797) Stomach Pathology biopsy report
24
110
2.57
3.56
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
18
75
2.71
3.19
1.6
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
27
140
2.28
3.04
2.4
1.9
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
28
151
2.20
2.86
3.0
1.9
mg/l
3.1
2.8
0.16
23
127
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
12
44
2.97
2.65
2.5
1.8
g/l
0.3
0.2
2.58
12
35
(3035350) Ketones [Presence] in Urine by Test strip
51
353
1.93
2.59
5.1
3.5
estimate
0.0
0.0
—
8
64
(40768793) Breast Pathology biopsy report
5
7
7.45
2.58
1.4
1.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
42
275
1.92
2.50
6.4
7.4
inr
1.1
1.2
—
8
82
(3037467) Urinalysis macro (dipstick) panel - Urine
66
502
1.96
2.49
5.3
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
52
367
1.89
2.45
6.3
5.0
e9/l
0.6
0.6
0.50
44
314
(3006315) Basophils [#/volume] in Blood
52
369
1.87
2.39
6.4
5.0
e9/l
0.1
0.0
0.91
45
315
(3034770) Mitochondria Ab [Titer] in Serum
8
23
3.69
2.32
1.4
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
52
372
1.85
2.30
6.3
5.0
e9/l
1.8
1.8
0.02
47
329
(3049717) Cytology report of Urine Cyto stain
7
18
4.10
2.30
2.0
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
32
197
1.93
2.25
3.3
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
19
3.88
2.19
1.4
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
90
2.23
2.17
1.7
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
39
259
1.84
2.16
6.0
2.7
—
—
—
0
0
(3015736) pH of Urine
41
277
1.83
2.15
4.8
3.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
51
369
1.80
2.13
5.2
3.4
estimate
0.0
0.0
—
9
63
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
10
5.20
2.09
1.0
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
45
2.63
2.01
2.5
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
43
300
1.77
2.00
2.3
1.8
pmol/l
89.4
97.1
0.54
26
136
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
33
2.90
1.99
1.1
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
52
386
1.74
1.93
6.7
5.1
e9/l
0.2
0.2
0.63
47
332
(3000850) Epithelial cells [#/volume] in Urine
25
150
1.89
1.87
5.6
1.9
e6/l
11.4
6.1
0.35
20
130
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
41
2.60
1.82
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
61
2.30
1.81
1.1
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
46
335
1.70
1.79
11.3
8.0
e9/l
0.0
0.0
0.00
35
262
(3030467) Casts [#/volume] in Urine by Automated count
31
202
1.78
1.78
6.7
2.6
e6/l
0.4
0.5
0.09
22
146
(3023368) Bacteria identified in Blood by Culture
28
177
1.81
1.78
4.8
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
18
3.48
1.77
1.3
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
18
3.48
1.77
1.3
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
14
69
2.20
1.75
1.6
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
49
365
1.68
1.75
8.2
4.7
estimate
0.0
0.0
—
9
66
(36304419) Bacteria [Presence] in Urine
30
196
1.76
1.70
6.7
2.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
42
302
1.68
1.70
2.9
2.3
nmol/l
70.7
77.0
0.95
37
262
(40760892) CBC W Ordered Manual Differential panel - Blood
26
164
1.80
1.65
6.1
4.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
14
3.70
1.63
1.6
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
30
200
1.72
1.58
1.5
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
37
2.57
1.52
4.2
2.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
88
787
2.16
1.51
18.5
10.7
mg/l
26.2
22.0
0.43
74
573
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
11
52
2.26
1.51
4.1
1.7
ml/min/173m2
54.4
53.9
—
5
15
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
20
120
1.84
1.48
4.3
2.6
e6/l
4.1
1.0
0.41
13
63
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
16
3.23
1.45
1.6
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
16
3.23
1.45
2.4
2.8
%
237.0
214.1
—
5
16
(3002582) Erythrocytes [#/volume] in Urine
32
223
1.65
1.42
6.8
2.7
e6/l
39.0
47.9
0.11
24
170
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
7
29
2.52
1.42
7.1
6.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
30
206
1.66
1.41
5.5
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
21
133
1.74
1.31
4.5
2.4
mosm/kgh2o
594.0
544.7
0.32
14
107
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
21
134
1.72
1.28
1.2
1.4
u/ml
1.1
11.9
1.71
11
53
(3018095) Leukocytes [#/volume] in Urine
35
257
1.56
1.24
7.9
3.4
e6/l
63.8
77.5
0.10
25
180
(3020564) Creatinine [Moles/volume] in Serum or Plasma
90
833
1.98
1.15
23.0
12.6
umol/l
81.5
78.1
0.36
90
833
(3009542) Hematocrit [Volume Fraction] of Blood
81
723
1.69
1.15
20.7
12.0
%
38.7
40.5
0.85
57
511
(3020630) Protein [Mass/volume] in Serum or Plasma
11
59
1.97
1.12
1.4
1.3
g/l
68.4
68.0
0.09
11
53
(3019550) Sodium [Moles/volume] in Serum or Plasma
88
806
1.90
1.10
22.2
13.0
mmol/l
139.6
139.8
0.26
88
777
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
45
2.10
1.08
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
16
99
1.74
1.08
2.4
1.8
ug/g
136.1
81.9
—
10
77
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
116
1.68
1.06
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
22
150
1.60
1.05
2.3
2.4
ug/l
0.6
0.8
1.00
16
96
(3023103) Potassium [Moles/volume] in Serum or Plasma
88
809
1.86
1.04
21.1
13.0
mmol/l
4.0
4.0
0.01
88
779
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
37
286
1.47
1.01
5.3
3.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
24
169
1.56
1.00
5.3
4.9
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
36
2.02
0.99
33.0
8.0
%
0.7
0.7
—
7
36
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
36
2.02
0.99
33.0
8.1
%
1.2
1.8
—
7
36
(3015377) Calcium [Moles/volume] in Serum or Plasma
29
214
1.50
0.98
3.3
1.9
mmol/l
2.3
2.4
0.30
24
186
(3004588) Protein electrophoresis panel - Serum or Plasma
9
51
1.84
0.97
1.1
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
24
173
1.51
0.90
1.2
1.3
u/ml
0.4
1.2
—
6
47
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
30
2.06
0.88
1.5
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
14
89
1.67
0.87
1.3
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
45
1.85
0.86
1.6
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
12
74
1.71
0.82
1.5
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
12
74
1.71
0.82
1.5
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
17
116
1.56
0.81
4.7
2.8
e6/l
0.2
3.5
—
10
60
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
142
1.51
0.80
1.2
1.3
iu/ml
13.0
35.2
—
5
53
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
21
151
1.50
0.80
3.2
3.2
ng/l
2894.8
275.2
0.42
16
115
(42870588) Differential panel, method unspecified - Blood
30
232
1.42
0.79
6.9
4.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
53
1.77
0.78
15.0
6.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
24
2.14
0.75
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
24
2.14
0.75
1.0
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
24
2.14
0.75
1.0
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
24
2.14
0.75
1.0
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
40
1.81
0.73
1.4
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
10
61
1.71
0.71
6.2
5.1
mmol/l
1.6
1.4
—
10
56
(3008898) HLA-B27 [Presence]
5
28
1.83
0.67
1.0
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
26
202
1.39
0.67
2.4
2.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
20
148
1.44
0.66
1.8
1.9
pmol/l
471.5
446.5
0.17
15
118
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
21
0.00
0.61
0.0
1.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
21
0.00
0.61
0.0
1.4
—
33.9
—
0
21
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
33
272
1.32
0.58
4.1
3.8
ug/l
2.1
2.0
0.09
33
243
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
59
1.58
0.57
1.6
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
37
1.66
0.56
1.5
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
37
1.66
0.56
2.5
2.9
mmol/l
25.5
25.1
—
6
37
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
6
37
1.66
0.56
3.3
3.8
%
35.8
52.7
—
6
37
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
27
217
1.34
0.56
3.0
3.6
%
22.8
24.9
0.40
14
107
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
91
1.49
0.56
7.2
6.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
21
164
1.36
0.52
4.3
3.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
9
65
1.42
0.52
3.1
2.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
14
103
1.42
0.48
1.4
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
21
167
1.33
0.47
1.9
1.5
nmol/l
17.3
23.0
1.57
21
139
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
15
0.00
0.41
0.0
1.3
—
7.6
—
0
9
(3039443) Prostate specific Ag panel - Serum or Plasma
0
17
0.00
0.41
0.0
1.7
—
—
—
0
0
(3019225) pH of Specimen
8
61
1.34
0.40
3.0
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
30
257
1.24
0.38
4.9
3.9
mg/mmol
7.2
9.2
0.14
21
159
(3012544) pH of Venous blood
9
69
1.33
0.38
9.3
3.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
41
1.49
0.37
1.5
1.3
—
—
—
0
0
(3013512) EKG study
26
222
1.23
0.34
4.3
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
60
558
1.19
0.32
4.4
3.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
33
291
1.20
0.32
3.8
3.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
28
245
1.20
0.29
4.0
3.2
mg/l
2560.9
66.7
0.48
18
153
(40761511) CBC panel - Blood by Automated count
86
831
1.28
0.28
19.2
10.2
—
—
—
0
0
(3000492) Spirometry study
8
66
1.23
0.27
1.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
72
0.68
0.27
1.2
1.8
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
6
83
0.71
0.25
1.8
2.1
ug/l
1.6
6.1
—
6
70
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
92
0.74
0.23
1.0
1.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
90
879
1.29
0.22
30.2
16.1
pg
30.1
30.3
0.59
90
859
(3000963) Hemoglobin [Mass/volume] in Blood
90
879
1.29
0.22
30.5
16.3
g/l
132.0
137.5
2.31
90
858
(3024731) MCV [Entitic volume]
90
878
1.31
0.22
30.2
16.2
fl
90.4
91.0
0.57
90
858
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
42
1.20
0.22
1.0
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
11
0.00
0.21
0.0
4.8
—
7.0
—
0
6
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
6
47
1.29
0.21
1.2
1.2
u/ml
200.1
282.2
—
6
41
(3037756) Immunofixation for Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
51
1.19
0.20
1.0
1.1
—
—
—
0
0
(4010399)
6
52
1.16
0.19
1.3
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
34
313
1.13
0.18
3.7
3.3
ng/l
35.9
46.4
0.21
24
210
(40761535) Cells panel - Urine sediment
7
61
1.16
0.18
2.0
2.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
76
736
1.15
0.17
19.6
10.3
ml/min/173m2
81.3
80.5
0.11
67
573
(3042936) Bacteria identified in Isolate by Culture
12
103
1.19
0.14
2.8
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
60
0.82
0.08
1.2
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
72
0.82
0.08
1.3
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
21
197
1.08
0.07
5.2
3.6
estimate
0.0
0.0
—
9
64
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
47
483
0.95
0.05
2.8
3.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
122
1.08
0.03
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
122
1.08
0.03
1.9
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
10
95
1.06
0.00
1.0
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
51
0.98
0.00
1.8
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
2.8
—
15.6
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
6.3
—
0
5
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
62
0.97
0.00
1.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
1.2
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
60
1.00
0.00
10.3
3.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
18.7
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
5.8
—
0
5
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
11.3
—
0
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
68.9
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_EXTRAHEPATIC_BILE_EXALLC – Benign neoplasm: Extrahepatic bile ducts
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).